A newly identifiedMAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes
Open Access
- 5 May 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 81 (3) , 387-394
- https://doi.org/10.1002/(sici)1097-0215(19990505)81:3<387::aid-ijc12>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- HLA‐A typing: comparison between serology, the amplification refractory mutation system with polymerasee chain reaction and sequencingTissue Antigens, 1997
- Differential binding of peptides substituted at putative C-terminal anchor residues to HLA-DQ8 and DQ9 differing only at β57Human Immunology, 1997
- Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the geneMAGE-3International Journal of Cancer, 1996
- Differential Anti-MART-1/MelanA CTL Activity in Peripheral Blood of HLA-A2 Melanoma Patients in Comparison to Healthy DonorsJournal of Immunotherapy, 1996
- DNA typing of the HLA‐A gene: population study and identification of four new alleles in JapaneseTissue Antigens, 1996
- Expression of the MAGE gene family in human head‐and‐neck squamous‐cell carcinomasInternational Journal of Cancer, 1995
- Expression of mage genes in transitional‐cell carcinomas of the urinary bladderInternational Journal of Cancer, 1995
- A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3European Journal of Immunology, 1994
- Structure, chromosomal localization, and expression of 12 genes of the MAGE familyImmunogenetics, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991